$10 million gift establishes pioneering Nano Oncology Center
Interdisciplinary research center to be named in honor of Ronald and JoAnne Willens
- Scientists using nanotechnology to fight cancer
- Attacking cancer at nanoscale offers significant promise over conventional treatments
- Center will advance Northwestern’s position as a world leader in nanoscience
EVANSTON, Ill. --- A new $10 million gift from Ronald and JoAnne Willens to Northwestern University’s International Institute for Nanotechnology (IIN) will establish an interdisciplinary research center that will use advances in nanotechnology to develop new cancer treatments. It will be one of the first centers of its kind in the country.
The Ronald and JoAnne Willens Center for Nano Oncology, headquartered within the IIN, will allow Northwestern scientists to develop nanotechnology-based therapeutics with substantial benefits over existing treatments. For example, one promise of nanotechnology-based therapeutics is the ability to target tumor cells in a way that minimizes side effects for patients.
The support from the Willenses will enable the IIN to accelerate its promising preliminary research that applies nanotechnology to cancer.
“The Willens Center promises to profoundly benefit cancer patients around the world with research leading to new treatments and cures,” Northwestern President Morton Schapiro said. “Ron and JoAnne are passionate about advancing cutting-edge technology that will result in positive patient outcomes, and we are very grateful for their generous support of Northwestern.”
In 2011, the couple gave Northwestern a $10 million gift to advance nanotechnology research. In honor of this gift, the top three floors of an addition to the Technological Institute, housing some of the University’s most outstanding nanoscientists and engineers, were named the Willens Engineering Life Sciences Wing.
Both $10 million gifts from the Willenses count toward We Will. The Campaign for Northwestern, a $3.75 billion University-wide fundraising effort announced in March 2014. The funds raised through the campaign will help realize the transformational vision set forth in Northwestern’s strategic plan and solidify the University’s position among the world’s leading research universities.
Conventional oncological cancer treatments face many challenges, including drug toxicity, difficulty delivering the therapy to tumor sites, and the ability of tumors to develop drug resistance. While chemotherapy effectively damages cancer cells, it also damages healthy cells leading to adverse side effects, some of which can be fatal. Given these complications, scientists are turning to nanotechnology in the fight against cancer.
Biological processes, including those that lead to cancer, are inherently nanoscale phenomena. Nanotechnology has the potential to generate entirely novel and highly effective therapeutic agents with the ability to attack cancer at its genetic roots. Nanotechnology-based therapeutics offer a number of benefits over traditional treatments, including longer half-lives, increased retention, improved targeting efficiency and fewer patient side effects.
“We are extremely excited to launch this new effort at Northwestern and are very grateful to the Willens family for their extraordinary generosity,” said Chad A. Mirkin, George B. Rathmann Professor of Chemistry in the Weinberg College of Arts and Sciences and the director of the IIN. “This center will lead to advances that will improve and save the lives of many people and also help further distinguish Northwestern as the world hub for nanomedicine research.”
A diversity of expertise is needed to make a difference in the complex challenge of cancer, and interdisciplinary research is a Northwestern hallmark. The Willens Center will bring together nanoscientists, cancer biologists, engineers and clinicians from two campuses and three Northwestern schools: Weinberg College, the McCormick School of Engineering and Applied Science and Northwestern University Feinberg School of Medicine.
“This gift will provide a great opportunity to have an important impact on the treatment of cancer,” said Jay Walsh, Northwestern’s vice president for research. “Ron and JoAnne have been wonderful supporters of the work being done by a great team of nanotechnology researchers — they can long be proud of their gift’s enduring impact.”
The Willenses cite Northwestern leadership along with their personal connection to the University as key factors in their decision to support the creation of the new nano oncology center.
“We are very pleased to continue our support of the creative and important nanotechnology research being done at Northwestern,” JoAnne Willens said. “The University is truly a global leader in nanoscience. The innovative work promises to have a significant impact on fighting cancer, which is important to us and society.”
Ron Willens added, “We also made this gift because of the excellent education our family has received at Northwestern and our confidence in President Schapiro’s leadership.”
Two of their sons and one granddaughter have graduated from Northwestern; another granddaughter will graduate in June.
Ron Willens is co-founder of the technology company Livingston Enterprises, which Lucent Technologies bought in 1997. The company made remote access equipment and software that allowed hundreds of users to dial into large corporate networks or Internet service providers.
JoAnne Willens is a retired technical illustrator.
More information on We Will. The Campaign for Northwestern is available at wewill.northwestern.edu.